Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

A noncanonical repressor function of JUN restrains YAP activity and suppresses YAP-dependent liver cancer growth

View through CrossRef
Abstract Yes-associated protein (YAP) and its homologue, transcriptional coactivator with PDZ-binding motif (TAZ), are the main transcriptional downstream effector of the Hippo pathway. Decreased Hippo pathway activity leads to nuclear translocation of YAP/TAZ where they interact with TEAD transcription factors to induce target gene expression. Unrestrained YAP/TAZ activity can lead to excessive growth and tumor formation in a short time, underscoring the evolutionary need for tight control of these two transcriptional coactivators. The AP-1 complex binds together with YAP/TAZ to many common sites and they form a positive feed-forward to induce gene expression. Here, we report that the AP-1 component c-JUN acts as specific repressor of YAP/TAZ at joint target sites to decrease YAP/TAZ activity. This function of c-JUN is independent of its heterodimeric AP-1 partner c-FOS demonstrating that it is independent of the canonical AP-1 function to induce target gene expression. Since c-JUN is itself by YAP/TAZ, our work identifies a negative feedback loop that buffers YAP/TAZ activity at joint sites. This negative feedback loop needs to get disrupted in liver cancer to unlock the full oncogenic potential of YAP/TAZ. Our results thus demonstrate an additional layer of control for the important interplay of YAP/TAZ and AP-1.
Title: A noncanonical repressor function of JUN restrains YAP activity and suppresses YAP-dependent liver cancer growth
Description:
Abstract Yes-associated protein (YAP) and its homologue, transcriptional coactivator with PDZ-binding motif (TAZ), are the main transcriptional downstream effector of the Hippo pathway.
Decreased Hippo pathway activity leads to nuclear translocation of YAP/TAZ where they interact with TEAD transcription factors to induce target gene expression.
Unrestrained YAP/TAZ activity can lead to excessive growth and tumor formation in a short time, underscoring the evolutionary need for tight control of these two transcriptional coactivators.
The AP-1 complex binds together with YAP/TAZ to many common sites and they form a positive feed-forward to induce gene expression.
Here, we report that the AP-1 component c-JUN acts as specific repressor of YAP/TAZ at joint target sites to decrease YAP/TAZ activity.
This function of c-JUN is independent of its heterodimeric AP-1 partner c-FOS demonstrating that it is independent of the canonical AP-1 function to induce target gene expression.
Since c-JUN is itself by YAP/TAZ, our work identifies a negative feedback loop that buffers YAP/TAZ activity at joint sites.
This negative feedback loop needs to get disrupted in liver cancer to unlock the full oncogenic potential of YAP/TAZ.
Our results thus demonstrate an additional layer of control for the important interplay of YAP/TAZ and AP-1.

Related Results

Age dependent endothelial responses to pneumonia-induced Acute Lung Injury
Age dependent endothelial responses to pneumonia-induced Acute Lung Injury
Objective: Children with Pediatric Acute Respiratory Distress Syndrome (PARDS) have better outcomes than adults with ARDS. Animal studies suggest that the reasons for improved outc...
YAP/TAZ reverse progestin resistance through PI3K-Akt pathway in endometrial carcinoma
YAP/TAZ reverse progestin resistance through PI3K-Akt pathway in endometrial carcinoma
AbstractBackground:Progestin resistance is a problem for patients with endometrial carcinoma (EC) who require conservative treatment with progestin, and its underlying mechanisms r...
Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers
Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers
Abstract YAP activation in cancer is linked to poor outcomes, making it an attractive therapeutic target. Previous research focused on blocking the interaction of...
Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers
Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers
ABSTRACT YAP activation in cancer is linked to poor outcomes, making it an attractive therapeutic target. Previous research focused on blocking the interaction of Y...
CDK9 is dispensable for YAP‐driven hepatoblastoma development
CDK9 is dispensable for YAP‐driven hepatoblastoma development
AbstractBackgroundHepatoblastoma (HB) is the most common pediatric liver malignancy, occurring mainly during the first 4 years of life. Recent studies unraveled the frequent, coord...
Expression of Yap Signaling Hippo Pathway in Cervical Pre-cancerous Lesions and Cervical Cancer
Expression of Yap Signaling Hippo Pathway in Cervical Pre-cancerous Lesions and Cervical Cancer
Abstract Objective: To determine the expression of YAP in cervical pre-cancerous and cervical cancer lesions.Methods: Researchers systematically searched five databases using the c...
Degradation determinants are abundant in human noncanonical proteins
Degradation determinants are abundant in human noncanonical proteins
Abstract The comprehensive characterization of human proteins, a key objective in contemporary biology, has been revolutionized by the identification of thousands o...
Intracellular Trp repressor levels in Escherichia coli
Intracellular Trp repressor levels in Escherichia coli
A radioimmunoassay for the Trp repressor protein of Escherichia coli was developed with antisera raised against purified Trp repressor protein. This assay was used to directly meas...

Back to Top